Former commissioners, Woodcock dissect pandemic response, future challenges at FDA

A panel of former US Food and Drug Administration (FDA) commissioners, as well as Acting FDA Commissioner Janet Woodcock, addressed the agency’s role in addressing the current and future pandemics, as well as their predictions for FDA’s near-term future.